Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial (no authoring)

Title: Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trial

DOI:10.1186/s12931-022-02126-2

2022-10-08

This was a public outcome of my involvement at UCB. I won’t go further in the presentation of the paper since I don’t endorse authorship for this work, my technical contribution was simply acknowledged for the visual output below.